Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

780 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Fulminant hepatitis and late onset hepatic failure in Japan.
Fujiwara K, Mochida S, Matsui A, Nakayama N, Nagoshi S, Toda G; Intractable Liver Diseases Study Group of Japan. Fujiwara K, et al. Among authors: nakayama n. Hepatol Res. 2008 Jul;38(7):646-57. doi: 10.1111/j.1872-034X.2008.00322.x. Epub 2008 Mar 5. Hepatol Res. 2008. PMID: 18328067
Case-control study for the identification of virological factors associated with fulminant hepatitis B.
Kusakabe A, Tanaka Y, Mochida S, Nakayama N, Inoue K, Sata M, Isoda N, Kang JH, Sumino Y, Yatsuhashi H, Takikawa Y, Kaneko S, Yamada G, Karino Y, Tanaka E, Kato J, Sakaida I, Izumi N, Sugauchi F, Nojiri S, Joh T, Miyakawa Y, Mizokami M. Kusakabe A, et al. Among authors: nakayama n. Hepatol Res. 2009 Jul;39(7):648-56. doi: 10.1111/j.1872-034X.2009.00519.x. Epub 2009 Apr 23. Hepatol Res. 2009. PMID: 19456899
Clinical impact of serum transforming growth factor-alpha mRNA as a predictive biomarker for the prognosis of fulminant hepatitis.
Miura N, Kabashima H, Shimizu M, Sato R, Tsukamoto T, Harada T, Takahashi S, Endo R, Nakayama N, Takikawa Y, Mochida S, Suzuki K, Hasegawa J, Shiota G. Miura N, et al. Among authors: nakayama n. Hepatol Int. 2008 Jun;2(2):213-21. doi: 10.1007/s12072-008-9053-6. Epub 2008 Apr 9. Hepatol Int. 2008. PMID: 19669307 Free PMC article.
Usefulness of miriplatin as an anticancer agent for transcatheter arterial chemoembolization in patients with unresectable hepatocellular carcinoma.
Imai Y, Chikayama T, Nakazawa M, Watanabe K, Ando S, Mizuno Y, Yoshino K, Sugawara K, Hamaoka K, Fujimori K, Inao M, Nakayama N, Oka M, Nagoshi S, Mochida S. Imai Y, et al. Among authors: nakayama n. J Gastroenterol. 2012 Feb;47(2):179-86. doi: 10.1007/s00535-011-0475-x. Epub 2011 Oct 6. J Gastroenterol. 2012. PMID: 21976133
780 results